Literature DB >> 8584312

Shigella lipopolysaccharide antibodies in pediatric populations.

J H Passwell1, S Freier, R Shor, N Farzam, C Block, M Lison, E Shiff, S Ashkenazi.   

Abstract

Shigellosis is the most common cause of bacterial dysentery. To study the specific immunity to the two major groups causing shigellosis, we assayed antibodies to lipopolysaccharide (LPS) by enzyme-linked immunoadsorbent assay to both Shigella sonnei and Shigella flexneri 2a serotypes in the following populations: (1) women immediately after delivery and their infants to assess the transfer of passive immunity by placenta and the presence of secretory antibodies in breast milk; (2) children of different ages; and (3) the kinetics of antibody production in pediatric patients, who had culture-proved shigellosis. The sera of these women showed variable concentrations of antibodies of all three isotypes to LPS of S. sonnei and S. flexneri 2a. These serotype-specific antibodies were not cross-reactive. Transfer of IgG anti-LPS across the placenta was significantly correlated with concentration of the specific antibody in the mother (S. sonnei, r = 0.96; S. flexneri, r = 0.84). Varying concentrations of anti-LPS IgA were present in colostrum, which was correlated with serum anti-LPS IgA titers in the case of S. sonnei (r = 0.44; P < 0.05) but not S. flexneri (r = 0.17). Healthy children between the ages of 6 months and 4 years in our population had undetectable or relatively low titers of anti-S. sonnei IgG. More children had detectable antibody titers to S. flexneri 2a than to S. sonnei. The relatively high concentrations of these natural antibodies are particularly noteworthy because there is a far lower incidence (< 10% of patients) with S. flexneri than with S. sonnei disease in this population.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584312     DOI: 10.1097/00006454-199510000-00008

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  An update on vaccines against Shigella.

Authors:  Shai Ashkenazi; Dani Cohen
Journal:  Ther Adv Vaccines       Date:  2013-09

2.  Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.

Authors:  Deborah H Schmiel; Elizabeth E Moran; Paul B Keiser; Brenda L Brandt; Wendell D Zollinger
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

3.  Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice.

Authors:  D Pavliakova; C Chu; S Bystricky; N W Tolson; J Shiloach; J B Kaufman; D A Bryla; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

Review 4.  Serum IgG antibodies to Shigella lipopolysaccharide antigens - a correlate of protection against shigellosis.

Authors:  Dani Cohen; Shiri Meron-Sudai; Anya Bialik; Valeria Asato; Sophy Goren; Ortal Ariel-Cohen; Arava Reizis; Amit Hochberg; Shai Ashkenazi
Journal:  Hum Vaccin Immunother       Date:  2019-05-09       Impact factor: 3.452

5.  Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel.

Authors:  J H Passwell; E Harlev; S Ashkenazi; C Chu; D Miron; R Ramon; N Farzan; J Shiloach; D A Bryla; F Majadly; R Roberson; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 6.  Detoxified O-Specific Polysaccharide (O-SP)-Protein Conjugates: Emerging Approach in the Shigella Vaccine Development Scene.

Authors:  Dani Cohen; Shiri Meron-Sudai; Anya Bialik; Valeria Asato; Shai Ashkenazi
Journal:  Vaccines (Basel)       Date:  2022-04-24

7.  O-specific [corrected] polysaccharide conjugate vaccine-induced [corrected] antibodies prevent invasion of Shigella into Caco-2 cells and may be curative.

Authors:  Yehuda Chowers; Joachim Kirschner; Nathan Keller; Iris Barshack; Simon Bar-Meir; Shai Ashkenazi; Rachel Schneerson; John Robbins; Justen H Passwell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-07       Impact factor: 11.205

8.  The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants.

Authors:  Corinne N Thompson; Thi Phuong Tu Le; Katherine L Anders; Trong Hieu Nguyen; Lan Vi Lu; Van Vinh Chau Nguyen; Thuy Duong Vu; Ngoc Minh Chau Nguyen; Thi Hong Chau Tran; Thanh Tuyen Ha; Vu Thieu Nga Tran; Van Minh Pham; Do Hoang Nhu Tran; Thi Quynh Nhi Le; Allan Saul; Laura B Martin; Audino Podda; Christiane Gerke; Guy Thwaites; Cameron P Simmons; Stephen Baker
Journal:  Vaccine       Date:  2015-12-29       Impact factor: 3.641

9.  Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis.

Authors:  Esther Ndungo; Liana R Andronescu; Andrea G Buchwald; Jose M Lemme-Dumit; Patricia Mawindo; Neeraj Kapoor; Jeff Fairman; Miriam K Laufer; Marcela F Pasetti
Journal:  Front Immunol       Date:  2021-10-15       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.